Biomarkers of Intrinsic Angiogenic and Anti-angiogenic Activity in Patients with Endometrial Hyperplasia and Endometrial Cancer

References

• Perazzini F, La Vechia C, Bocciolone C, Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol 1991; 41: 1–4.
   PubMedGoogle Scholar
• Folkman J, Klagsburn M. Vascular physiology. A family of angiogenic peptides. Nature 1987; 329: 671–2.
   Google Scholar
• Zhang L, Scott PA, Turley H, et al. Validation of anti-vascu-lar endothelial growth factor antibodies for immunohisto-chemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J Path 1998; 185: 402–8.
   PubMed Web of Science ®Google Scholar
• Torry DS, Holt VJ, Keenan JA, Harris G, Caudle MR, Tony RJ. Vascular endothelial growth factor expression in cycling human endometrium. Fertil steril 1996; 66: 72–80.
   PubMed Web of Science ®Google Scholar
• Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med 1998; 49: 407–24.
   PubMed Web of Science ®Google Scholar
• Kaku T, Kamura T, Kinukawa N, et al. Angiogenesis in endometrial carcinoma. Cancer 1997; 80: 241–7.
   Google Scholar
• Kim KJ, Li B, Winner J, et al. Inhibition of VEGF-induced angiogenesis suppresses tumor growth in vivo. Nature 1993; 362: 341–4.
   Google Scholar
• Chopra V, Dinh TV, Hannigan EV. Serum levels of inter-leukins, growth factors and angiogenin in patients with en-dometrial cancer. J Cancer Res Clin Oncol 1997; 123: 167–72.
   Google Scholar
• Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF. Expression of VEGF and its receptors in endometrial carcinoma. Cancer 1996; 78: 454–60.
   PubMed Web of Science ®Google Scholar
• Doldi N, Bassan M, Gulisano M, Broccoli V, Boncinelli E, Ferrari A. Vascular endothelial growth factor messenger ri-bonucleic acid expression in human ovarian and endometrial cancer. Gynecol Endocrinol 1996; 10: 375–82.
   PubMed Web of Science ®Google Scholar
• Ferrara N. The role of VEGF in pathological angiogenesis. Breast Cancer Res Treat 1995; 36: 127–37.
   PubMedGoogle Scholar
• Widner N. Tumor angiogenesis, review of current application in tumor prognostication. Semin Diagn Pathol 1993; 10: 302–18.
   PubMedGoogle Scholar
• Blood CH, Zetter BR. Tumor interaction with the vascula-ture; angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89–118.
   PubMed Web of Science ®Google Scholar
• Bigler SA, Brawer MK, Deering RE, et al. Vessel density in carcinoma of the prostate: comparing organ confined tumors with stage D tumors. Mol Path 1993; 6: 56a.
   Google Scholar
• Muechiarini P, Fontaini G, Hardin MJ, et al. Relation of neovasculature to metastasis of non-small cell lung cancer. Lancet 1992; 340: 145–6.
   PubMedGoogle Scholar
• Obermair A, Wanner C, Bilgi S, et al. Tumour angiogenesis in stage IB cervical cancer: correlation of micovessel density with survival. Am J Obstet Gynecol 1998; 178: 314–9.
   PubMed Web of Science ®Google Scholar
• Van Hoef MEHM, Knox WF, Dhesi SS, et al. Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 1993; 29: 1141–5.
   Google Scholar
• Bouck N, Stellmach V, Hsu SQ. How tumors become angiogenic. Adv Cancer Res 1996; 69: 153�74.
   Google Scholar
• Shaarawy M, Shobokshi A, Abdel-Salam I. The clinical value of detecting extracellular domain of c-erb B-2 oncoprotein and p53 tumor suppressor gene mutant protein in hyperplastic and malignant endometrium. Arab J Lab Med 2000; 26: 1�6.
   Google Scholar
• Lannutti BJ, Gately ST, Quevedo ME, Soff GA, Patler AS. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. Cancer Res 1997; 57: 5277 �80.
   Google Scholar
• Standker L, Schrader M, Kanse SM, Jurgens M, Forssmann WG, Peissner KT. Isolation and characterization of the circulating form of human endostatin. FEBS-Lett 1997; 420: 129�33.
   Google Scholar
• Folkman J. Tumor angiogenesis. In: Holland JF, Frei E, Bast RC, et al., eds. Cancer medicine, 3rd ed. Philadelphia: PA Lea & Fabiger, 1992.
   Google Scholar
• Szabo S, Sandor Z. The diagnostic and prognostic value of tumor angiogenesis. Eur J Surg 1998; 582 (Suppl): 99–103.
   Google Scholar
• O'Reilly MS. Endostatin: an endogenous inhibitor of angio-genesis and tumor growth. Cell 1997; 88: 277–85.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353–64.
   PubMed Web of Science ®Google Scholar
• Blezinger P, Wang J, Gondo M, et al. Systemic inhibition of tumor growth and tumor metastasis by intramuscular admin-istration of the endostatin gene. Nature Biotech 1999; 17: 343–8.
   PubMed Web of Science ®Google Scholar